Prevention, treatment side effects focus of SABCS Thursday
Breast cancer prevention and management of unpleasant treatment side effects topped today’s presentations at the San Antonio Breast Cancer Symposium, co-hosted by Baylor College of Medicine.
One of studies identified a new treatment for breast cancer reduction, while another showed exercise might help patients better cope with the unpleasant side effect of joint pain, which is commonly associated with cancer treatment.
The meeting is broadly followed by journalists from around the world, with more than 160 attending the meeting onsite and many others covering remotely.
Read today’s headlines:
Exercise helps women tolerate breast cancer drugs
New therapy slashes breast cancer rates 50 percent; results unveiled in San Antonio symposium
New drug combinations and new clues about the biology of certain breast cancer tumors was also a focus:
PIK3CA Gene Mutations Make HER2- and Hormone Receptor-positive Breast Cancers Treatment-resistant
New Drug Combination Delayed Disease Progression for Subgroup of Women With Metastatic Breast Cancer
In addition to presentations in the general oral session, SABCS also highlights research in poster presentations held in the morning and evening. Tonight an abstract authored by BCM Drs. Jin-Ah Kim, Xixi Cao, Ying Tan, Xian Wang, Rachel Schiff and Xiaosong Wang was featured in a poster session.
They presented new research on TLK2, a gene aberration associated with invasive breast cancer. The study showed the gene could be a potential therapeutic target.
Read more about the history of the conference and see the highlight’s from Wednesday’s session.
Join the conversation and follow @bcmhouston for updates from San Antonio throughout the week and follow #sabcs13 for tweets from the conference.
-By Glenna Picton